Arvinas
在场
高管
查看带有其 38 名主要高管的组织结构图
Arvinas 搜索最多的简介
- John Houston, President, Chief Executive Officer and Chairman of t...
- Everett Cunningham, Director
- Ted Kennedy, Director
高管在Arvinas变化
- Andrew Saik已作为Chief Financial Officer and Treasurer加入公司 (新闻发布的2024六月25号).
- Ian Taylor 曾任 Chief Scientific Officer, 现升职为 President of Research and Development (新闻发布的2024六月18号).
- Randy Teel 曾任 Interim Chief Financial Officer and Treasurer, 现升职为 Chief Business Officer, Interim Chief Financial Officer and Treasurer (新闻发布的2024四月25号).
创建提醒
跟踪 Arvinas 的高管变动
生物技术
Arvinas 拥有 2,327 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- Alentis Therapeutics 刚刚宣布为 181 筹款数百万美元。 (公布2024十一月20号).
- Metsera 刚刚宣布为 500 筹款数百万美元。 (公布2024十一月20号).
- TRexBio 刚刚宣布为 84 筹款数百万美元。 (公布2024十一月14号).
生物技术 行业的其他推荐联系人
消息
Arvinas 的最新新闻稿
- Arvinas Announces Pipeline Programs Targeting Validated and Classically “Undruggable” Disease-Causing Proteins | Arvinas
- Arvinas to Present at the 3rd Annual Targeted Protein Degradation Summit | Arvinas
- Arvinas to Present at the Citi 15th Annual BioPharma Virtual Conference | Arvinas
- Arvinas to Present at the 2020 Wedbush PacGrow Virtual Healthcare Conference | Arvinas
- Arvinas Reports Second Quarter 2020 Financial Results and Provides Corporate Update | Arvinas
- Arvinas Appoints Wendy Dixon, Ph.D., to its Board of Directors | Arvinas
- Arvinas | News
- Arvinas | News
- News Releases | Arvinas
- Arvinas Completes $55 Million Series C Financing to Advance Protein Degradation Platform - Arvinas, Inc.
- View more press releases Close
通过电子邮件
